Medtronic Endeavor DES 4-Month Data Bode Well For Pivotal Studies – Firm

Medtronic is taking heart from Boston Scientific's TAXUS IV paclitaxel-eluting stent study results indicating that a late lumen loss of 0.39 mm in-stent was associated with an 8% restenosis rate